The Response of Drug Expenditures to Non-Linear Contract Design : Evidence from Medicare Part D
Year of publication: |
2013
|
---|---|
Authors: | Einav, Liran |
Other Persons: | Finkelstein, Amy (contributor) ; Schrimpf, Paul (contributor) |
Publisher: |
[2013]: [S.l.] : SSRN |
Subject: | Arzneimittel | Pharmaceuticals | Gesetzliche Krankenversicherung | Public health insurance | Gesundheitskosten | Health care costs | Schätzung | Estimation |
Extent: | 1 Online-Ressource (77 p) |
---|---|
Series: | NBER Working Paper ; No. w19393 |
Type of publication: | Book / Working Paper |
Language: | English |
Notes: | Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments August 2013 erstellt |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Wen, Hefei, (2014)
-
Does medicaid pay too much for precscription drugs? : A case study of atypical anti-psychotics
Duggan, Mark G., (2003)
-
Maclean, Catherine, (2017)
- More ...
-
Einav, Liran, (2010)
-
The welfare cost of asymmetric information : evidence from the UK annuity market
Einav, Liran, (2007)
-
Selection on moral hazard in health insurance
Einav, Liran, (2011)
- More ...